Basis for selection of anticoagulant drugs for therapeutic trials in human malignancyZACHARSKI, L. R.Haemostasis. 1986, Vol 16, Num 3-4, pp 300-320, issn 0301-0147Article

Rationale for treatment of cancer with calcium antagonists. A reviewZACHARSKI, L. R.Journal of medicine (Westbury). 1988, Vol 19, Num 3-4, pp 145-177, issn 0025-7850Article

Treatment of small cell carcinoma of the lungZACHARSKI, L. R.Lancet (British edition). 1992, Vol 339, Num 8807, pp 1476-1477, issn 0140-6736Article

The role of fibrin in tumor metastasisCOSTANTINI, V; ZACHARSKI, L. R.Cancer metastasis reviews. 1992, Vol 11, Num 3-4, pp 283-290, issn 0167-7659Article

Fibrin and cancerCOSTANTINI, V; ZACHARSKI, L. R.Thrombosis and haemostasis. 1993, Vol 69, Num 5, pp 406-414, issn 0340-6245Article

Heparin and cancerZACHARSKI, L. R; ORNSTEIN, D. L.Thrombosis and haemostasis. 1998, Vol 80, Num 1, pp 10-23, issn 0340-6245Article

Anticoagulants and cancer therapyZACHARSKI, L. R; MEEHAN, K. R.The Cancer journal (Print). 1993, Vol 6, Num 1, pp 16-20, issn 0765-7846Article

Registry of clinical trials of antithrombotic drugs in cancer. The scientific and standardization committee of the international society on thrombosis and haemostasis subcommittee on hemostasis and malignancyZACHARSKI, L. R; DONATI, M. B.Thrombosis and haemostasis. 1989, Vol 61, Num 3, pp 526-528, issn 0340-6245Article

Registry of clinical trials of antithrombotic drugs in cancer : second reportZACHARSKI, L. R; DONATI, M. B; RICKLES, F. R et al.Thrombosis and haemostasis. 1993, Vol 70, Num 2, pp 357-360, issn 0340-6245Article

Thrombin-specific sites of fibrinogen in small cell carcinoma of the lungZACHARSKI, L. R; MEMOLI, V. A; ROUSSEAU, S. M et al.Cancer. 1988, Vol 62, Num 2, pp 299-302, issn 0008-543XArticle

Pregnancy complicated by thrombotic thrombocytopenic purpura with fetal sparingBLAKOWSKI, S. A; ZACHARSKI, L. R; TELFER, M. C et al.Archives of internal medicine (1960). 1983, Vol 143, Num 11, pp 2207-2208, issn 0003-9926Article

In vitro stimulation of monocyte tissue factor activity by autologous plateletsPINDER, P. B; HUNT, J. A; ZACHARSKI, L. R et al.American journal of hematology. 1985, Vol 19, Num 4, pp 317-325, issn 0361-8609Article

Coagulation-cancer interaction in situ in renal cell carcinomaZACHARSKI, L. R; MEMOLI, V. A; ROUSSEAU, S. M et al.Blood. 1986, Vol 68, Num 2, pp 394-399, issn 0006-4971Article

Occurrence of fibrin and tissue factor antigen in human small cell carcinoma of the lung = Présence de fibrine et de l'antigène du facteur tissulaire dans le carcinome à petites cellules humain du poumonZACHARSKI, L. R; SCHNED, A. R; SORENSON, G. D et al.Cancer research (Baltimore). 1983, Vol 43, Num 8, pp 3963-3968, issn 0008-5472Article

Cellular localization of enzymatically active thrombin in intact human tissues by hirudin bindingZACHARSKI, L. R; MEMOLI, V. A; MORAIN, W. D et al.Thrombosis and haemostasis. 1995, Vol 73, Num 5, pp 793-797, issn 0340-6245Article

Prognostic significance of blood coagulation tests in carcinoma of the lung and colonWOJTUKIEWICZ, M. Z; ZACHARSKI, L. R; MORITZ, T. E et al.Blood coagulation & fibrinolysis. 1992, Vol 3, Num 4, pp 429-437, issn 0957-5235Article

Effect of warfarin anticoagulation on survival in carcinoma of the lung, colon, head and neck, and prostate = Effet de l'anticoagulation par warfarine sur la survie des cancers du poumon, du côlon de la tête et du cou et de la prostateZACHARSKI, L. R; HENDERSON, W. G; ÓDELL, R et al.Cancer. 1984, Vol 53, Num 10, pp 2046-2052, issn 0008-543XArticle

Influence of age, performance status, body weight, and tumor type in individuals with cancer on the disposition of warfarin and its enantiomers : department of veterans affairs cooperative study number 75FORMAN, W. B; COOK, C. E; ZACHARSKI, L. R et al.The Journal of laboratory and clinical medicine. 1992, Vol 119, Num 3, pp 280-284, issn 0022-2143Article

Clinical trials with anticoagulant and antiplatelet therapiesZACHARSKI, L. R; MEEHAN, K. R; ALGARRA, S. M et al.Cancer metastasis reviews. 1992, Vol 11, Num 3-4, pp 421-431, issn 0167-7659Article

Abnormalities of blood coagulation tests in patients with cancerEDWARDS, R. L; RICKLES, F. R; SANG-HEE KIM et al.American journal of clinical pathology. 1987, Vol 88, Num 5, pp 596-602, issn 0002-9173Article

Association studies between haemochromatosis gene mutations and the risk of cardiovascular diseases. CommentarySULLIVAN, J. L; ZACHARSKI, L. R; SIMON, A et al.European journal of clinical investigation. 2001, Vol 31, Num 5, pp 375-377, issn 0014-2972, 10 p.Article

Expression of tissue factor and tissue factor pathway inhibitor in situ in laryngeal carcinomaWOJTUKIEWICZ, M. Z; ZACHARSKI, L. R; RUCINSKA, M et al.Thrombosis and haemostasis. 1999, Vol 82, Num 6, pp 1659-1662, issn 0340-6245Article

Inhibition of HIV-1 infectivity by low molecular weight heparin : Results of in vitro studies and a pilot clinical trial in patients with advanced AIDSHOWELL, A. L; TAYLOR, T. H; MILLER, J. D et al.International journal of clinical & laboratory research. 1996, Vol 26, Num 2, pp 124-131, issn 0940-5437Article

Pretreatment fibrinogen levels are associated with response to chemotherapy in patients with small cell carcinoma of the lung : Department of Veterans Affairs Cooperative Study 188MEEHAN, K. R; ZACHARSKI, L. R; MORITZ, T. E et al.American journal of hematology. 1995, Vol 49, Num 2, pp 143-148, issn 0361-8609Article

Absence of components of coagulation and fibrinolysis pathways in situ in mesotheliomaWOJTUKIEWICZ, M. Z; ZACHARSKI, L. R; MEMOLI, V. A et al.Thrombosis research. 1989, Vol 55, Num 2, pp 279-284, issn 0049-3848Article